Healthcare provider profile · identity verified

Edgard Quinones, MD

Internal Medicine · WALDEN, NY · NPI 1659444321

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	215	63
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	204	31
Levothyroxine Sodium	Levothyroxine Sodium	188	55
Atorvastatin Calcium	Atorvastatin Calcium	146	47
Albuterol Sulfate Hfa	Albuterol Sulfate	141	43
Azithromycin	Azithromycin	137	88
Furosemide	Furosemide	115	43
Losartan Potassium	Losartan Potassium	109	34
Oxycodone Hcl	Oxycodone Hcl	109	16
Metformin Hcl	Metformin Hcl	107	30
Pantoprazole Sodium	Pantoprazole Sodium	104	40
Metoprolol Tartrate	Metoprolol Tartrate	103	37
Tamsulosin Hcl	Tamsulosin Hcl	96	29
Gabapentin	Gabapentin	89	30
Methylprednisolone	Methylprednisolone	89	54
Omeprazole	Omeprazole	85	33
Rosuvastatin Calcium	Rosuvastatin Calcium	81	22
Alprazolam	Alprazolam	79	18
Lisinopril	Lisinopril	74	22
Simvastatin	Simvastatin	68	21
Valsartan	Valsartan	68	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	66	suppressed
Prosol	Parenteral Amino Acid 20% No.1	63	suppressed
Pregabalin	Pregabalin	61	suppressed
Metoprolol Succinate	Metoprolol Succinate	60	20
Prednisone	Prednisone	58	17
Zolpidem Tartrate	Zolpidem Tartrate	57	16
Eliquis	Apixaban	52	suppressed
Carvedilol	Carvedilol	51	14
Sevelamer Carbonate	Sevelamer Carbonate	48	16
Allopurinol	Allopurinol	47	13
Trazodone Hcl	Trazodone Hcl	47	suppressed
Glimepiride	Glimepiride	46	12
Hydrochlorothiazide	Hydrochlorothiazide	45	16
Fluticasone Propionate	Fluticasone Propionate	44	15
Clopidogrel	Clopidogrel Bisulfate	42	15
Ropinirole Hcl	Ropinirole Hcl	40	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	13
Glipizide	Glipizide	39	11
Clonazepam	Clonazepam	38	suppressed
Famotidine	Famotidine	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Sertraline Hcl	Sertraline Hcl	33	12
Calcium Acetate	Calcium Acetate	31	11
Clonidine Hcl	Clonidine Hcl	31	suppressed
Diazepam	Diazepam	31	suppressed
Meloxicam	Meloxicam	31	17
Labetalol Hcl	Labetalol Hcl	29	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	26	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Nystatin	Nystatin	25	14
Ozempic	Semaglutide	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	14
Amoxicillin	Amoxicillin	23	11
Cefuroxime	Cefuroxime Axetil	23	17
Duloxetine Hcl	Duloxetine Hcl	23	suppressed
Finasteride	Finasteride	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Tradjenta	Linagliptin	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	14
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	12
Meclizine Hcl	Meclizine Hcl	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Cephalexin	Cephalexin	19	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	11
Colchicine	Colchicine	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Potassium Chloride	Potassium Chloride	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Nabumetone	Nabumetone	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Baclofen	Baclofen	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Linzess	Linaclotide	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Vancomycin Hcl	Vancomycin Hcl	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Tacrolimus	Tacrolimus	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Lubiprostone	Lubiprostone	11	suppressed
Modafinil	Modafinil	11	suppressed
Ofloxacin	Ofloxacin	11	suppressed
Pristiq	Desvenlafaxine Succinate	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error